Literature DB >> 12631370

Myofibroblastic conversion of mesothelial cells.

An Hang Yang1, Jinn Yang Chen, Jen Kou Lin.   

Abstract

BACKGROUND: The continuous chemical, physical, and inflammatory insults of prolonged continuous ambulatory peritoneal dialysis (CAPD) incite mesothelial cell responses, which may result in peritoneal fibrosis. The transforming growth factor-beta (TGF-beta), especially the isoform TGF-beta 1, has long been known to play crucial role in the fibrogenic process. Although several studies have implicated TGF-beta in peritoneal fibrosis, the underlying mechanism has not been completely elucidated.
METHODS: To test the effects of exogenous TGF-beta 1 on mesothelial cells, we assessed cytoarchitectural changes of human peritoneal mesothelial cells (HPMC) in in vitro culture by light, immunofluorescent, electron and immunoelectron microscopy, and differential gene expression analysis using semiquantitative reverse transcription-polymerase chain reaction (RT-PCR) and cDNA expression array assays.
RESULTS: The TGF-beta 1-induced myofibroblastic conversion was a transdifferentiation process resulting in characteristic myofibroblastic phenotype that included prominent rough endoplasmic reticuli (rER) with dilated cisternas, conspicuous smooth muscle actin (SMA) myofilaments, frequent intercellular intermediate and gap junctions, and active deposition of extracellular matrix (ECM) and formation of fibronexus. The gene expression array analysis revealed complex modulation of gene expression involving cytoskeletal organization, cell adhesion, ECM production, cell proliferation, innate immunity, cytokine/growth factor signaling, cytoprotection, stress response, and many other essential metabolic processes in mesothelial cells.
CONCLUSION: This report describes myofibroblastic conversion of mesothelial cells, a previously undefined, yet frequently speculated, cell adaptive or pathogenic process. Our study helps to elucidate the complex molecular and cellular events involved in myofibroblastic conversion of mesothelial cells. We propose that differentiated epithelial cells of mesothelium convert or transdifferentiate into myofibroblasts, which implies the recruitment of fibrogenic cells from mesothelium during serosal inflammation and wound healing.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12631370     DOI: 10.1046/j.1523-1755.2003.00861.x

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  56 in total

1.  miR-9-5p suppresses pro-fibrogenic transformation of fibroblasts and prevents organ fibrosis by targeting NOX4 and TGFBR2.

Authors:  Marta Fierro-Fernández; Óscar Busnadiego; Pilar Sandoval; Cristina Espinosa-Díez; Eva Blanco-Ruiz; Macarena Rodríguez; Héctor Pian; Ricardo Ramos; Manuel López-Cabrera; Maria Laura García-Bermejo; Santiago Lamas
Journal:  EMBO Rep       Date:  2015-08-27       Impact factor: 8.807

2.  Lineage tracing reveals distinctive fates for mesothelial cells and submesothelial fibroblasts during peritoneal injury.

Authors:  Yi-Ting Chen; Yu-Ting Chang; Szu-Yu Pan; Yu-Hsiang Chou; Fan-Chi Chang; Pei-Ying Yeh; Yuan-Hung Liu; Wen-Chih Chiang; Yung-Ming Chen; Kwan-Dun Wu; Tun-Jun Tsai; Jeremy S Duffield; Shuei-Liong Lin
Journal:  J Am Soc Nephrol       Date:  2014-05-22       Impact factor: 10.121

3.  Histone acetyltransferase inhibitor C646 reverses epithelial to mesenchymal transition of human peritoneal mesothelial cells via blocking TGF-β1/Smad3 signaling pathway in vitro.

Authors:  Yiya Yang; Kanghan Liu; Yumei Liang; Yinyin Chen; Ying Chen; Yuting Gong
Journal:  Int J Clin Exp Pathol       Date:  2015-03-01

Review 4.  Transition of mesothelial cell to fibroblast in peritoneal dialysis: EMT, stem cell or bystander?

Authors:  Yu Liu; Zheng Dong; Hong Liu; Jiefu Zhu; Fuyou Liu; Guochun Chen
Journal:  Perit Dial Int       Date:  2015 Jan-Feb       Impact factor: 1.756

Review 5.  Encapsulating peritoneal sclerosis: the state of affairs.

Authors:  Mario R Korte; Denise E Sampimon; Michiel G H Betjes; Raymond T Krediet
Journal:  Nat Rev Nephrol       Date:  2011-08-02       Impact factor: 28.314

Review 6.  The Current State of Peritoneal Dialysis.

Authors:  Rajnish Mehrotra; Olivier Devuyst; Simon J Davies; David W Johnson
Journal:  J Am Soc Nephrol       Date:  2016-06-23       Impact factor: 10.121

7.  Blocking TGF-β1 protects the peritoneal membrane from dialysate-induced damage.

Authors:  Jesús Loureiro; Abelardo Aguilera; Rafael Selgas; Pilar Sandoval; Patricia Albar-Vizcaíno; María Luisa Pérez-Lozano; Vicente Ruiz-Carpio; Pedro L Majano; Santiago Lamas; Fernando Rodríguez-Pascual; Francisco Borras-Cuesta; Javier Dotor; Manuel López-Cabrera
Journal:  J Am Soc Nephrol       Date:  2011-07-08       Impact factor: 10.121

8.  CAM5.2-positive subserosal myofibroblasts in appendicitis.

Authors:  Tadashi Hamauzu; Naoto Kuroda; Limei Guo; Eriko Miyazaki; Yoshihiro Hayashi; Makoto Toi; Makoto Hiroi; Hideaki Enzan
Journal:  Med Mol Morphol       Date:  2006-12-21       Impact factor: 2.309

9.  Hagfish and lancelet fibrillar collagens reveal that type II collagen-based cartilage evolved in stem vertebrates.

Authors:  Guangjun Zhang; Martin J Cohn
Journal:  Proc Natl Acad Sci U S A       Date:  2006-10-31       Impact factor: 11.205

Review 10.  Pleural mesothelial cells in pleural and lung diseases.

Authors:  Hitesh Batra; Veena B Antony
Journal:  J Thorac Dis       Date:  2015-06       Impact factor: 2.895

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.